Regenerate with Austenite

The main pharmaco-therapeutic effect: a implicated himerychni / t mouse / human, that specifically bind to transmembranym a / g implicated and agriculture is located on pre-B lymphocytes and implicated B-lymphocytes, but not on stovburovyhyh hematopoietic cells, pro- B-cells, healthy cells and plasma of healthy cells of other tissues, implicated expressed in more than 95% of B-cell lymphomas nehodzhkinskyh, after binding and / t internalizuyetsya SV20 is not removed from the membrane into the environment. Indications for use of drugs: Non-Hodgkin's lymph - recurrent or resistant here chemotherapy of B-cells, SV20-positive Non-Hodgkin's lymphoma of low degree of malignancy or follicular, SV20-positive diffusion in velykoklitynni-Hodgkin's Lymphomas Grain combination with chemotherapy scheme Snoro; follicular lymphoma FE-IV stage, chemotherapy-resistant or recurrent (second or subsequent relapse after chemotherapy), previously untreated follicular lymphoma stage III-IV in implicated with chemotherapy Suryo, supportive therapy follicular lymphomas after receiving responses Nia induction therapy of RA. Contraindications to the use of drugs: hypersensitivity to the drug, CNS metastatic lesions, pregnancy, lactation, infancy, renal and hepatic failure. Pharmacotherapeutic group: L01XC02 - antitumor agents (monoclonal and / t). trastuzumab inhibits implicated proliferation of human tumor cells, characterized by hyperexpression of HER2. Side effects and complications in the use of drugs: abdominal pain, diarrhea, nausea, vomiting, asthenia, chest pain, fever, chills, backache, flu-like s-m, infection, pain in the neck, malaise, AR, vasodilatation, tachycardia, hypotension, heart failure, cardiomyopathy, palpitation, anorexia, constipation, indigestion, leukopenia, edema, bone pain, anxiety, depression, here drowsiness, insomnia, paresthesia, hypertension, neuropathy, asthma, cough, dyspnea, nasal bleeding, pathology of implicated lungs, pleural effusion, pharyngitis, rhinitis, sinusitis, cystitis, urethritis, itching, sweating, nail lesions, dry skin, hair loss, acne, makulo-papular rash, in the first infusion often chills, fever and may kupiruvatysya by with analgesics or type of refrigerant meperydynu or paracetamol, or antihistamines, such dyfenhidraminu; iInodi infusion reaction to a drug, that appears dyspnea, hypotension, appearance rattle in the lungs, bronchospasm, tachycardia, decrease in oxygen saturation and respiratory distress with-IOM can be severe and, in rare cases lead to fatal outcome, CH, shortness of breath, ortopnoe, increased cough, lung edema, gallop and three-term reduction of ejection fraction, hematotoksychnist, hepatotoksychnosti phenomenon accompanied the progression of metastatic liver damage. Contraindications to the use of drugs: hypersensitivity to the drug or other substance in it. Pharmacotherapeutic group: L01XC03 - antitumor agents. Dosing and Administration of drugs: before treatment trastuzumabom testing tumor HER2 expression is mandatory Hertseptynom; Cytosine Diphosphate mode dosage - loading dose: 4 mg / kg body weight in a 90-minute / v infusion (patients Non-Gonococcal Urethritis watch for the occurrence of fever, chills or other infusion reactions, these symptoms can be eliminated by interrupting infusion, the symptoms disappear after infusion renewest) supporting dose: 2 mg / kg per week if previous dose postponed well, the drug can be entered as a 30-minute infusion; enter drug / fluid can implicated be in, safety and efficacy in the treatment of children trastuzumabu not installed. mh/10 100 ml, 500 ml mh/50. N zoster); violation lacrimation, conjunctivitis, breach of taste Randomized Controlled Trial Contraindications to the use of drugs: hypersensitivity to the drug or the mouse protein. Method of production Sodium Nitroprusside drugs: a concentrate for making Mr infusion vial.